| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | PDPN CACNA1C SLC9B1 SLC26A3 ABCA2 ATP6V0B KCNU1 SLC9B2 BAK1 GJC1 SLC17A7 MFSD4A GRIK4 NMUR2 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A1 SLC2A2 SLC2A3 SLC45A4 ITPR1 ITPR2 | 1.00e-13 | 1180 | 65 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | PDPN CACNA1C SLC9B1 SLC26A3 ABCA2 ATP6V0B KCNU1 SLC9B2 BAK1 GJC1 SLC17A7 MFSD4A GRIK4 NMUR2 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A1 SLC2A2 SLC2A3 SLC45A4 ITPR1 ITPR2 | 6.80e-13 | 1289 | 65 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | PDPN CACNA1C SLC9B1 SLC26A3 ATP6V0B KCNU1 SLC9B2 SLC17A7 GRIK4 NMUR2 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC45A4 ITPR1 ITPR2 | 2.00e-10 | 758 | 65 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C SLC9B1 SLC26A3 ATP6V0B KCNU1 SLC9B2 GJC1 SLC17A7 GRIK4 NMUR2 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC45A4 ITPR1 ITPR2 | 4.00e-10 | 793 | 65 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB2 EPHB3 TSPAN12 GPR161 OR51E1 PRLHR TPRA1 ADRA2C ADRB2 PTPRM OR6K2 PLXNC1 OR5D18 OR51M1 HLA-DRA MFSD6 MCHR2 OR10W1 GRIK4 NMUR2 ADGRD1 | 8.22e-10 | 1353 | 65 | 21 | GO:0004888 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C SLC9B1 ATP6V0B KCNU1 SLC9B2 SLC17A7 GRIK4 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC45A4 ITPR1 ITPR2 | 1.09e-08 | 627 | 65 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C SLC9B1 ATP6V0B KCNU1 SLC9B2 SLC17A7 GRIK4 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC45A4 ITPR1 ITPR2 | 2.24e-08 | 664 | 65 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C SLC9B1 KCNU1 SLC9B2 SLC17A7 GRIK4 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 2.91e-08 | 465 | 65 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC9B1 SLC26A3 ATP6V0B SLC9B2 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC45A4 | 4.49e-08 | 301 | 65 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.18e-08 | 171 | 65 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.42e-07 | 42 | 65 | 5 | GO:0015144 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC9B1 SLC26A3 ABCA2 ATP6V0B SLC9B2 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC45A4 | 3.60e-07 | 477 | 65 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 1.23e-06 | 25 | 65 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 1.23e-06 | 25 | 65 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.70e-06 | 27 | 65 | 4 | GO:0015145 | |
| GeneOntologyMolecularFunction | dehydroascorbic acid transmembrane transporter activity | 1.82e-06 | 8 | 65 | 3 | GO:0033300 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 2.28e-06 | 29 | 65 | 4 | GO:0051119 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 3.89e-06 | 10 | 65 | 3 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 3.89e-06 | 10 | 65 | 3 | GO:0005391 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR161 OR51E1 PRLHR TPRA1 ADRA2C ADRB2 OR6K2 OR5D18 OR51M1 MCHR2 OR10W1 NMUR2 ADGRD1 | 4.45e-06 | 884 | 65 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.77e-06 | 293 | 65 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 5.33e-06 | 11 | 65 | 3 | GO:0008556 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 5.57e-06 | 36 | 65 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 5.57e-06 | 36 | 65 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 5.57e-06 | 36 | 65 | 4 | GO:0090482 | |
| GeneOntologyMolecularFunction | channel activity | PDPN CACNA1C KCNU1 BAK1 GJC1 SLC17A7 GRIK4 NMUR2 ITPR1 ITPR2 | 7.08e-06 | 525 | 65 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | PDPN CACNA1C KCNU1 BAK1 GJC1 SLC17A7 GRIK4 NMUR2 ITPR1 ITPR2 | 7.20e-06 | 526 | 65 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.72e-05 | 167 | 65 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.81e-05 | 109 | 65 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | ceramide-1-phosphate phosphatase activity | 3.12e-05 | 3 | 65 | 2 | GO:0106235 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 3.12e-05 | 3 | 65 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 3.35e-05 | 188 | 65 | 6 | GO:0015078 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.88e-05 | 193 | 65 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.35e-05 | 197 | 65 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 4.95e-05 | 62 | 65 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | peptide binding | 7.67e-05 | 318 | 65 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | antiporter activity | 8.68e-05 | 138 | 65 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 9.11e-05 | 27 | 65 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.04e-04 | 334 | 65 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.17e-04 | 459 | 65 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | galactose transmembrane transporter activity | 1.55e-04 | 6 | 65 | 2 | GO:0005354 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate phosphatase activity | 2.17e-04 | 7 | 65 | 2 | GO:0042392 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.85e-04 | 178 | 65 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 3.70e-04 | 9 | 65 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 3.70e-04 | 43 | 65 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.00e-04 | 296 | 65 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 4.62e-04 | 10 | 65 | 2 | GO:0004935 | |
| GeneOntologyMolecularFunction | P-type proton-exporting transporter activity | 4.62e-04 | 10 | 65 | 2 | GO:0008553 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 5.45e-04 | 49 | 65 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 5.69e-04 | 207 | 65 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.81e-04 | 208 | 65 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | catecholamine binding | 7.95e-04 | 13 | 65 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 7.95e-04 | 13 | 65 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 9.26e-04 | 14 | 65 | 2 | GO:0008195 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 9.26e-04 | 14 | 65 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.07e-03 | 15 | 65 | 2 | GO:0005005 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.13e-03 | 140 | 65 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.22e-03 | 16 | 65 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 1.22e-03 | 16 | 65 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.49e-03 | 151 | 65 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.54e-03 | 18 | 65 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 1.72e-03 | 19 | 65 | 2 | GO:0042577 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.72e-03 | 19 | 65 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.34e-03 | 171 | 65 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 2.39e-03 | 172 | 65 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 3.47e-03 | 27 | 65 | 2 | GO:0023026 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.57e-03 | 31 | 65 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | hormone binding | 4.62e-03 | 103 | 65 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 4.86e-03 | 32 | 65 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 4.86e-03 | 32 | 65 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.87e-03 | 105 | 65 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 4.88e-03 | 210 | 65 | 4 | GO:0019903 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.16e-03 | 33 | 65 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.17e-03 | 343 | 65 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 6.46e-03 | 37 | 65 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 6.46e-03 | 37 | 65 | 2 | GO:0022829 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.89e-03 | 119 | 65 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 7.88e-03 | 41 | 65 | 2 | GO:0008227 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 7.88e-03 | 41 | 65 | 2 | GO:0023023 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.89e-03 | 125 | 65 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | odorant binding | 8.24e-03 | 127 | 65 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 8.26e-03 | 42 | 65 | 2 | GO:0051721 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.60e-03 | 129 | 65 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 9.34e-03 | 133 | 65 | 3 | GO:0008528 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | EPHB2 CACNA1C SLC9B1 SLC26A3 ATP6V0B ADRB2 KCNU1 SLC9B2 BAK1 GJC1 SLC17A7 GRIK4 NMUR2 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 1.10e-09 | 1115 | 66 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | EPHB2 HFE CACNA1C SLC9B1 SLC26A3 ATP6V0B ADRB2 KCNU1 SLC9B2 BAK1 GJC1 SLC17A7 GRIK4 NMUR2 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 5.46e-09 | 1374 | 66 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 3.10e-08 | 11 | 66 | 4 | GO:0010248 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | HFE CACNA1C SLC9B1 SLC26A3 ABCA2 ATP6V0B SLC9B2 BAK1 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A2 ITPR1 ITPR2 | 5.52e-08 | 981 | 66 | 16 | GO:0019725 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | HFE CACNA1C SLC9B1 SLC26A3 ABCA2 ATP6V0B SLC9B2 BAK1 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A2 ITPR1 ITPR2 | 7.13e-08 | 866 | 66 | 15 | GO:0055082 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1C SLC9B1 SLC26A3 ATP6V0B ADRB2 KCNU1 SLC9B2 BAK1 SLC17A7 NMUR2 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 9.06e-08 | 1017 | 66 | 16 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | HFE CACNA1C SLC9B1 SLC26A3 ATP6V0B SLC9B2 BAK1 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 3.00e-07 | 705 | 66 | 13 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | HFE CACNA1C SLC9B1 SLC26A3 ATP6V0B SLC9B2 BAK1 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 3.63e-07 | 717 | 66 | 13 | GO:0050801 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | HFE CACNA1C SLC9B1 SLC26A3 ATP6V0B BAK1 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 4.68e-07 | 611 | 66 | 12 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | HFE CACNA1C SLC9B1 SLC26A3 ATP6V0B BAK1 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 5.66e-07 | 622 | 66 | 12 | GO:0006873 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1C SLC9B1 ATP6V0B ADRB2 KCNU1 SLC9B2 BAK1 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 1.02e-06 | 922 | 66 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 1.18e-06 | 170 | 66 | 7 | GO:1902600 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1C SLC9B1 ATP6V0B ADRB2 KCNU1 SLC9B2 BAK1 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 1.31e-06 | 942 | 66 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | chemical homeostasis | HFE CACNA1C SLC9B1 SLC26A3 ABCA2 ATP6V0B SLC9B2 BAK1 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A2 ITPR1 ITPR2 | 1.43e-06 | 1249 | 66 | 16 | GO:0048878 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | CACNA1C ABCA2 ADRA2C ADRB2 PTPRM ATP1A2 ATP1A4 SLC2A1 SLC2A3 | 1.44e-06 | 344 | 66 | 9 | GO:0003018 |
| GeneOntologyBiologicalProcess | regulation of pH | 2.34e-06 | 120 | 66 | 6 | GO:0006885 | |
| GeneOntologyBiologicalProcess | dehydroascorbic acid transport | 2.59e-06 | 9 | 66 | 3 | GO:0070837 | |
| GeneOntologyBiologicalProcess | metal ion transport | HFE CACNA1C SLC9B1 ADRB2 KCNU1 SLC9B2 BAK1 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 2.65e-06 | 1000 | 66 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.65e-06 | 275 | 66 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | HFE CACNA1C SLC9B1 ATP6V0B ADRB2 KCNU1 SLC9B2 BAK1 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 ITPR1 ITPR2 | 2.82e-06 | 1157 | 66 | 15 | GO:0006812 |
| GeneOntologyBiologicalProcess | positive regulation of signaling receptor activity | 3.65e-06 | 33 | 66 | 4 | GO:2000273 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.51e-06 | 208 | 66 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | organic anion transport | PDPN SLC26A3 CD47 SLC17A7 NMUR2 ATP1A2 SLC4A5 SLC2A1 SLC2A2 SLC2A3 | 5.20e-06 | 515 | 66 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 8.68e-06 | 87 | 66 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 8.71e-06 | 230 | 66 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | vascular transport | 9.18e-06 | 88 | 66 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid metabolic process | 1.70e-05 | 16 | 66 | 3 | GO:0019852 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.80e-05 | 101 | 66 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1C ABCA2 ADRA2C ADRB2 PTPRM GJC1 ATP1A2 ATP1A4 SLC4A5 SLC2A1 SLC2A3 | 1.91e-05 | 733 | 66 | 11 | GO:0003013 |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 2.06e-05 | 17 | 66 | 3 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 2.06e-05 | 17 | 66 | 3 | GO:0036376 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell surface | 2.13e-05 | 51 | 66 | 4 | GO:2000008 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 2.13e-05 | 51 | 66 | 4 | GO:0055078 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPR161 OR51E1 PRLHR TPRA1 ADRA2C ADRB2 PLPP1 OR6K2 OR5D18 OR51M1 MCHR2 OR10W1 NMUR2 ADGRD1 ITPR1 | 2.65e-05 | 1395 | 66 | 15 | GO:0007186 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | HFE CACNA1C SLC9B2 BAK1 SLC17A7 ATP1A2 ATP12A ATP1A4 ITPR1 ITPR2 | 2.67e-05 | 622 | 66 | 10 | GO:0098771 |
| GeneOntologyBiologicalProcess | lactone metabolic process | 2.92e-05 | 19 | 66 | 3 | GO:1901334 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 HFE PDPN HLA-DMA PLPP3 PTPRM LRFN5 HLA-DRA FAT3 LRFN3 CD164 CD47 CLDN1 | 3.08e-05 | 1077 | 66 | 13 | GO:0098609 |
| GeneOntologyBiologicalProcess | vitamin transport | 3.10e-05 | 56 | 66 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 3.67e-05 | 395 | 66 | 8 | GO:0050803 | |
| GeneOntologyBiologicalProcess | sphingosine metabolic process | 3.99e-05 | 21 | 66 | 3 | GO:0006670 | |
| GeneOntologyBiologicalProcess | sphingoid metabolic process | 5.29e-05 | 23 | 66 | 3 | GO:0046519 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 6.04e-05 | 24 | 66 | 3 | GO:0031290 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 6.25e-05 | 426 | 66 | 8 | GO:0043010 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 6.74e-05 | 133 | 66 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 6.79e-05 | 217 | 66 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | retina layer formation | 6.84e-05 | 25 | 66 | 3 | GO:0010842 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 6.92e-05 | 559 | 66 | 9 | GO:0042391 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 7.72e-05 | 26 | 66 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 9.19e-05 | 142 | 66 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 9.19e-05 | 142 | 66 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | D-glucose import across plasma membrane | 1.00e-04 | 5 | 66 | 2 | GO:0098708 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.03e-04 | 76 | 66 | 4 | GO:0048002 | |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 1.19e-04 | 30 | 66 | 3 | GO:0006883 | |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 1.20e-04 | 79 | 66 | 4 | GO:0034394 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 1.20e-04 | 79 | 66 | 4 | GO:0006940 | |
| GeneOntologyBiologicalProcess | import into cell | HFE CACNA1C ABCA2 ADRB2 SLC9B2 CD47 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC2A1 SLC2A3 | 1.36e-04 | 1074 | 66 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | eye development | 1.43e-04 | 480 | 66 | 8 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 1.49e-04 | 483 | 66 | 8 | GO:0150063 | |
| GeneOntologyBiologicalProcess | carbohydrate import across plasma membrane | 1.50e-04 | 6 | 66 | 2 | GO:0098704 | |
| GeneOntologyBiologicalProcess | hexose import across plasma membrane | 1.50e-04 | 6 | 66 | 2 | GO:0140271 | |
| GeneOntologyBiologicalProcess | galactose transmembrane transport | 1.50e-04 | 6 | 66 | 2 | GO:0015757 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB2 EPHB3 HFE PDPN HLA-DMA PLPP3 PLXNC1 HLA-DRA LRFN3 CD164 CD47 | 1.59e-04 | 927 | 66 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | sensory system development | 1.67e-04 | 491 | 66 | 8 | GO:0048880 | |
| GeneOntologyBiologicalProcess | diol metabolic process | 1.74e-04 | 34 | 66 | 3 | GO:0034311 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.90e-04 | 35 | 66 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 1.90e-04 | 35 | 66 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | carbohydrate transmembrane transport | 2.02e-04 | 168 | 66 | 5 | GO:0034219 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.19e-04 | 171 | 66 | 5 | GO:0048593 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 2.25e-04 | 37 | 66 | 3 | GO:0055075 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 2.33e-04 | 272 | 66 | 6 | GO:0006813 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 2.33e-04 | 387 | 66 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 2.35e-04 | 94 | 66 | 4 | GO:0051453 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 2.63e-04 | 39 | 66 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 2.84e-04 | 40 | 66 | 3 | GO:0045762 | |
| GeneOntologyBiologicalProcess | neural retina development | 3.21e-04 | 102 | 66 | 4 | GO:0003407 | |
| GeneOntologyBiologicalProcess | carbohydrate transport | 3.24e-04 | 186 | 66 | 5 | GO:0008643 | |
| GeneOntologyBiologicalProcess | amide transport | 3.82e-04 | 420 | 66 | 7 | GO:0042886 | |
| GeneOntologyBiologicalProcess | fructose transmembrane transport | 4.46e-04 | 10 | 66 | 2 | GO:0015755 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | CACNA1C SLC26A3 ADRB2 PLPP1 BAK1 ATP1A2 ATP12A SLC2A2 CLDN1 ITPR1 ITPR2 | 4.55e-04 | 1048 | 66 | 11 | GO:0014070 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 4.60e-04 | 309 | 66 | 6 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 4.72e-04 | 202 | 66 | 5 | GO:0035296 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 4.72e-04 | 202 | 66 | 5 | GO:0006937 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 4.72e-04 | 202 | 66 | 5 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 4.72e-04 | 202 | 66 | 5 | GO:0051963 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 4.83e-04 | 203 | 66 | 5 | GO:0035150 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 4.88e-04 | 48 | 66 | 3 | GO:0031281 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 4.88e-04 | 48 | 66 | 3 | GO:0002478 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 4.92e-04 | 313 | 66 | 6 | GO:0098742 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 4.94e-04 | 204 | 66 | 5 | GO:0048592 | |
| GeneOntologyBiologicalProcess | sensory organ development | EPHB2 TSPAN12 CACNA1C HLA-DMA PTPRM FAT3 BAK1 SLC17A7 SLC4A5 | 5.05e-04 | 730 | 66 | 9 | GO:0007423 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 5.10e-04 | 580 | 66 | 8 | GO:0022407 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 5.19e-04 | 49 | 66 | 3 | GO:0051349 | |
| GeneOntologyBiologicalProcess | regulation of synapse pruning | 5.44e-04 | 11 | 66 | 2 | GO:1905806 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 5.75e-04 | 211 | 66 | 5 | GO:0060041 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 5.84e-04 | 51 | 66 | 3 | GO:1990573 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 5.94e-04 | 120 | 66 | 4 | GO:0006835 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 6.54e-04 | 53 | 66 | 3 | GO:0071320 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 6.54e-04 | 53 | 66 | 3 | GO:1903115 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 7.36e-04 | 127 | 66 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 8.26e-04 | 131 | 66 | 4 | GO:0010469 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 8.28e-07 | 55 | 66 | 5 | GO:0098533 | |
| GeneOntologyCellularComponent | caveola | 1.37e-06 | 111 | 66 | 6 | GO:0005901 | |
| GeneOntologyCellularComponent | membrane raft | 1.97e-06 | 362 | 66 | 9 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.06e-06 | 364 | 66 | 9 | GO:0098857 | |
| GeneOntologyCellularComponent | apical part of cell | HFE PDPN SLC26A3 ADRB2 PLPP1 SLC9B2 ATP12A SLC4A5 SLC2A1 SLC2A2 CLDN1 | 2.24e-06 | 592 | 66 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | basal part of cell | 2.80e-06 | 378 | 66 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | apical plasma membrane | PDPN SLC26A3 ADRB2 PLPP1 SLC9B2 ATP12A SLC4A5 SLC2A1 SLC2A2 CLDN1 | 2.82e-06 | 487 | 66 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | neuron to neuron synapse | EPHB2 CACNA1C LRFN1 ADRA2C PLXNC1 LRFN5 LRFN3 GRIK4 CAP2 ITPR1 | 5.29e-06 | 523 | 66 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | plasma membrane raft | 7.01e-06 | 147 | 66 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 7.34e-06 | 320 | 66 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1C ABCA2 ATP6V0B KCNU1 SLC17A7 GRIK4 ATP1A2 ATP12A ATP1A4 SLC2A1 | 8.23e-06 | 550 | 66 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.02e-05 | 157 | 66 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | synaptic membrane | EPHB2 CACNA1C LRFN1 ADRA2C ADRB2 LRFN5 LRFN3 GRIK4 SLC2A3 ITPR1 | 1.36e-05 | 583 | 66 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | basal plasma membrane | 1.53e-05 | 354 | 66 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 1.73e-05 | 49 | 66 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.82e-05 | 477 | 66 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | presynapse | EPHB2 CACNA1C LRFN1 ADRA2C LRFN3 SLC9B2 CD47 SLC17A7 GRIK4 SLC2A1 SLC2A3 ITPR1 | 1.86e-05 | 886 | 66 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | cell surface | EPHB2 HFE PDPN CACNA1C LRFN1 HLA-DMA LRFN5 HLA-DRA LRFN3 TSPAN8 TMPRSS11D CD47 ATP1A2 | 3.71e-05 | 1111 | 66 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1C ABCA2 ATP6V0B KCNU1 SLC17A7 GRIK4 ATP1A2 ATP12A ATP1A4 | 3.74e-05 | 523 | 66 | 9 | GO:1902495 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.99e-05 | 405 | 66 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 4.12e-05 | 201 | 66 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | MHC protein complex | 7.42e-05 | 26 | 66 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | postsynaptic density | 8.47e-05 | 451 | 66 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 EPHB3 CACNA1C CNTNAP3B ADRA2C ADRB2 FAT3 LRFN3 CNTNAP3 GRIK4 ATP1A2 SLC2A3 ITPR1 | 1.03e-04 | 1228 | 66 | 13 | GO:0036477 |
| GeneOntologyCellularComponent | plasma membrane protein complex | HFE CACNA1C ABCA2 HLA-DMA HLA-DRA GJC1 GRIK4 ATP1A2 ATP12A ATP1A4 | 1.65e-04 | 785 | 66 | 10 | GO:0098797 |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.79e-04 | 503 | 66 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GPR161 ABCA2 ATP6V0B ADRB2 HLA-DMA HLA-DRA CD164 SLC9B2 CD47 SLC17A7 SLC2A3 ITPR1 ITPR2 | 1.92e-04 | 1307 | 66 | 13 | GO:0030659 |
| GeneOntologyCellularComponent | membrane protein complex | HFE CACNA1C ABCA2 ATP6V0B KCNU1 HLA-DMA HLA-DRA BAK1 GJC1 SLC17A7 GRIK4 ATP1A2 ATP12A ATP1A4 | 2.00e-04 | 1498 | 66 | 14 | GO:0098796 |
| GeneOntologyCellularComponent | vesicle membrane | GPR161 ABCA2 ATP6V0B ADRB2 HLA-DMA HLA-DRA CD164 SLC9B2 CD47 SLC17A7 SLC2A3 ITPR1 ITPR2 | 2.19e-04 | 1325 | 66 | 13 | GO:0012506 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 CACNA1C ADRA2C ADRB2 PLXNC1 LRFN5 LRFN3 CD47 GRIK4 SLC2A3 | 2.28e-04 | 817 | 66 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | endosome | HFE GPR161 ABCA2 ATP6V0B ADRA2C ADRB2 HLA-DMA HLA-DRA CD164 SLC9B2 ATP1A2 SLC2A2 | 2.59e-04 | 1167 | 66 | 12 | GO:0005768 |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 CACNA1C CNTNAP3B ADRA2C ADRB2 CNTNAP3 GRIK4 ATP1A2 SLC2A3 ITPR1 | 2.72e-04 | 835 | 66 | 10 | GO:0043025 |
| GeneOntologyCellularComponent | postsynapse | EPHB2 CACNA1C LRFN1 ADRA2C ADRB2 LRFN5 LRFN3 GRIK4 ATP1A2 CAP2 ITPR1 | 3.17e-04 | 1018 | 66 | 11 | GO:0098794 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 3.48e-04 | 9 | 66 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | axon | EPHB2 CACNA1C CNTNAP3B ADRA2C ADRB2 LRFN3 CNTNAP3 SLC17A7 GRIK4 ITPR2 | 4.55e-04 | 891 | 66 | 10 | GO:0030424 |
| GeneOntologyCellularComponent | platelet dense tubular network | 5.30e-04 | 11 | 66 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | sperm flagellum | 5.78e-04 | 214 | 66 | 5 | GO:0036126 | |
| GeneOntologyCellularComponent | cell body | EPHB2 CACNA1C CNTNAP3B ADRA2C ADRB2 CNTNAP3 GRIK4 ATP1A2 SLC2A3 ITPR1 | 6.30e-04 | 929 | 66 | 10 | GO:0044297 |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 6.35e-04 | 12 | 66 | 2 | GO:0005890 | |
| GeneOntologyCellularComponent | perikaryon | 6.96e-04 | 223 | 66 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 9.32e-04 | 238 | 66 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.21e-03 | 147 | 66 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 1.29e-03 | 17 | 66 | 2 | GO:0042613 | |
| GeneOntologyCellularComponent | intercalated disc | 1.30e-03 | 68 | 66 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | dendrite | 1.44e-03 | 858 | 66 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.46e-03 | 860 | 66 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.82e-03 | 277 | 66 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 2.33e-03 | 293 | 66 | 5 | GO:0030658 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.56e-03 | 591 | 66 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | endosome membrane | 2.84e-03 | 602 | 66 | 7 | GO:0010008 | |
| GeneOntologyCellularComponent | sarcolemma | 3.07e-03 | 190 | 66 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 3.28e-03 | 94 | 66 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.54e-03 | 212 | 66 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 4.77e-03 | 215 | 66 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | motile cilium | 5.26e-03 | 355 | 66 | 5 | GO:0031514 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 6.70e-03 | 237 | 66 | 4 | GO:0030136 | |
| GeneOntologyCellularComponent | sperm principal piece | 8.53e-03 | 44 | 66 | 2 | GO:0097228 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.01e-02 | 141 | 66 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | anchoring junction | 1.15e-02 | 976 | 66 | 8 | GO:0070161 | |
| MousePheno | behavioral despair | 1.92e-05 | 44 | 51 | 4 | MP:0002573 | |
| Domain | MFS_dom | 4.12e-07 | 134 | 65 | 7 | IPR020846 | |
| Domain | P-type_ATPase_IIC | 7.99e-07 | 6 | 65 | 3 | IPR005775 | |
| Domain | MFS | 2.04e-06 | 108 | 65 | 6 | PS50850 | |
| Domain | Ig-like_fold | EPHB2 EPHB3 HFE LRFN1 HLA-DMA PTPRM PLXNC1 LRFN5 HLA-DRA LRFN3 CD47 SEMA3G | 4.96e-06 | 706 | 65 | 12 | IPR013783 |
| Domain | Sugar/inositol_transpt | 1.42e-05 | 14 | 65 | 3 | IPR003663 | |
| Domain | - | EPHB2 EPHB3 HFE LRFN1 PTPRM PLXNC1 LRFN5 HLA-DRA LRFN3 CD47 SEMA3G | 1.62e-05 | 663 | 65 | 11 | 2.60.40.10 |
| Domain | GPCR_Rhodpsn_7TM | GPR161 OR51E1 PRLHR ADRA2C ADRB2 OR6K2 OR5D18 OR51M1 MCHR2 OR10W1 NMUR2 | 1.79e-05 | 670 | 65 | 11 | IPR017452 |
| Domain | Galactose-bd-like | 1.89e-05 | 94 | 65 | 5 | IPR008979 | |
| Domain | 7tm_1 | GPR161 OR51E1 PRLHR ADRA2C ADRB2 OR6K2 OR5D18 OR51M1 MCHR2 OR10W1 NMUR2 | 1.97e-05 | 677 | 65 | 11 | PF00001 |
| Domain | - | 2.18e-05 | 16 | 65 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.18e-05 | 16 | 65 | 3 | IPR023298 | |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR161 OR51E1 PRLHR ADRA2C ADRB2 OR6K2 OR5D18 OR51M1 MCHR2 OR10W1 NMUR2 | 2.19e-05 | 685 | 65 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR161 OR51E1 PRLHR ADRA2C ADRB2 OR6K2 OR5D18 OR51M1 MCHR2 OR10W1 NMUR2 | 2.38e-05 | 691 | 65 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR161 OR51E1 PRLHR ADRA2C ADRB2 OR6K2 OR5D18 OR51M1 MCHR2 OR10W1 NMUR2 | 2.41e-05 | 692 | 65 | 11 | IPR000276 |
| Domain | SUGAR_TRANSPORT_2 | 2.64e-05 | 17 | 65 | 3 | PS00217 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.64e-05 | 17 | 65 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.64e-05 | 17 | 65 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 3.16e-05 | 18 | 65 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 3.16e-05 | 18 | 65 | 3 | SM00831 | |
| Domain | InsP3_rcpt-bd | 3.57e-05 | 3 | 65 | 2 | IPR000493 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.75e-05 | 19 | 65 | 3 | IPR004014 | |
| Domain | IG_LIKE | 4.82e-05 | 491 | 65 | 9 | PS50835 | |
| Domain | Ig-like_dom | 5.81e-05 | 503 | 65 | 9 | IPR007110 | |
| Domain | FN3 | 6.64e-05 | 199 | 65 | 6 | PS50853 | |
| Domain | SUGAR_TRANSPORT_1 | 7.73e-05 | 24 | 65 | 3 | PS00216 | |
| Domain | FN3_dom | 8.71e-05 | 209 | 65 | 6 | IPR003961 | |
| Domain | MHC_II_alpha | 1.77e-04 | 6 | 65 | 2 | PF00993 | |
| Domain | RIH_assoc | 1.77e-04 | 6 | 65 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.77e-04 | 6 | 65 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.77e-04 | 6 | 65 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.77e-04 | 6 | 65 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.77e-04 | 6 | 65 | 2 | IPR015925 | |
| Domain | - | 1.77e-04 | 6 | 65 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.77e-04 | 6 | 65 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 1.77e-04 | 6 | 65 | 2 | PF08709 | |
| Domain | Sugar_transporter_CS | 1.86e-04 | 32 | 65 | 3 | IPR005829 | |
| Domain | - | 1.86e-04 | 32 | 65 | 3 | 3.40.1110.10 | |
| Domain | - | 1.86e-04 | 32 | 65 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 2.43e-04 | 35 | 65 | 3 | IPR023299 | |
| Domain | MHC_II_a_N | 2.48e-04 | 7 | 65 | 2 | IPR001003 | |
| Domain | fn3 | 2.51e-04 | 162 | 65 | 5 | PF00041 | |
| Domain | MFS_sugar_transport-like | 2.65e-04 | 36 | 65 | 3 | IPR005828 | |
| Domain | P_typ_ATPase | 2.65e-04 | 36 | 65 | 3 | IPR001757 | |
| Domain | Sugar_tr | 2.65e-04 | 36 | 65 | 3 | PF00083 | |
| Domain | ATPase_P-typ_P_site | 2.65e-04 | 36 | 65 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 2.65e-04 | 36 | 65 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.87e-04 | 37 | 65 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.87e-04 | 37 | 65 | 3 | PF00122 | |
| Domain | LAM_G_DOMAIN | 3.11e-04 | 38 | 65 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 3.63e-04 | 40 | 65 | 3 | PF02210 | |
| Domain | FN3 | 4.61e-04 | 185 | 65 | 5 | SM00060 | |
| Domain | LamG | 4.81e-04 | 44 | 65 | 3 | SM00282 | |
| Domain | MIR | 5.27e-04 | 10 | 65 | 2 | PS50919 | |
| Domain | MIR | 5.27e-04 | 10 | 65 | 2 | PF02815 | |
| Domain | MIR | 5.27e-04 | 10 | 65 | 2 | SM00472 | |
| Domain | MIR_motif | 5.27e-04 | 10 | 65 | 2 | IPR016093 | |
| Domain | ADR_fam | 5.27e-04 | 10 | 65 | 2 | IPR002233 | |
| Domain | 7TM_GPCR_Srsx | 6.26e-04 | 112 | 65 | 4 | SM01381 | |
| Domain | Ephrin_rec_like | 6.43e-04 | 11 | 65 | 2 | PF07699 | |
| Domain | Ion_trans_dom | 6.69e-04 | 114 | 65 | 4 | IPR005821 | |
| Domain | Ion_trans | 6.69e-04 | 114 | 65 | 4 | PF00520 | |
| Domain | IGc1 | 9.78e-04 | 56 | 65 | 3 | SM00407 | |
| Domain | ConA-like_dom | 9.88e-04 | 219 | 65 | 5 | IPR013320 | |
| Domain | Na_H_Exchanger | 1.06e-03 | 14 | 65 | 2 | PF00999 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.06e-03 | 14 | 65 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.06e-03 | 14 | 65 | 2 | PS00790 | |
| Domain | Eph_TM | 1.06e-03 | 14 | 65 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.06e-03 | 14 | 65 | 2 | IPR001426 | |
| Domain | EPH_lbd | 1.06e-03 | 14 | 65 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 1.06e-03 | 14 | 65 | 2 | PF01404 | |
| Domain | Cation/H_exchanger | 1.06e-03 | 14 | 65 | 2 | IPR006153 | |
| Domain | EphA2_TM | 1.06e-03 | 14 | 65 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.06e-03 | 14 | 65 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.06e-03 | 14 | 65 | 2 | IPR001090 | |
| Domain | EPH_LBD | 1.06e-03 | 14 | 65 | 2 | PS51550 | |
| Domain | Laminin_G | 1.08e-03 | 58 | 65 | 3 | IPR001791 | |
| Domain | Ig_C1-set | 1.08e-03 | 58 | 65 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 1.08e-03 | 58 | 65 | 3 | IPR003006 | |
| Domain | IG_MHC | 1.19e-03 | 60 | 65 | 3 | PS00290 | |
| Domain | - | 1.76e-03 | 18 | 65 | 2 | 1.20.144.10 | |
| Domain | acidPPc | 1.76e-03 | 18 | 65 | 2 | SM00014 | |
| Domain | - | 2.10e-03 | 73 | 65 | 3 | 2.60.120.260 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 2.18e-03 | 20 | 65 | 2 | IPR000326 | |
| Domain | PAP2 | 2.18e-03 | 20 | 65 | 2 | PF01569 | |
| Domain | FA58C | 2.40e-03 | 21 | 65 | 2 | SM00231 | |
| Domain | FA58C_3 | 2.40e-03 | 21 | 65 | 2 | PS50022 | |
| Domain | Tetraspanin_CS | 2.40e-03 | 21 | 65 | 2 | IPR018503 | |
| Domain | FA58C_1 | 2.40e-03 | 21 | 65 | 2 | PS01285 | |
| Domain | FA58C_2 | 2.40e-03 | 21 | 65 | 2 | PS01286 | |
| Domain | MFS_1 | 2.45e-03 | 77 | 65 | 3 | PF07690 | |
| Domain | MFS | 2.45e-03 | 77 | 65 | 3 | IPR011701 | |
| Domain | HAD-like_dom | 2.63e-03 | 79 | 65 | 3 | IPR023214 | |
| Domain | F5_F8_type_C | 3.13e-03 | 24 | 65 | 2 | PF00754 | |
| Domain | FA58C | 3.13e-03 | 24 | 65 | 2 | IPR000421 | |
| Domain | Ephrin_rec_like | 3.40e-03 | 25 | 65 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.40e-03 | 25 | 65 | 2 | IPR011641 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.25e-07 | 61 | 55 | 6 | MM15071 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | HFE SLC9B1 SLC26A3 ABCA2 ATP6V0B SLC9B2 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A1 SLC2A2 SLC2A3 | 2.28e-07 | 681 | 55 | 14 | MM14985 |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.42e-07 | 72 | 55 | 6 | MM14631 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.52e-07 | 78 | 55 | 6 | M1921 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | HFE SLC9B1 SLC26A3 ABCA2 ATP6V0B SLC9B2 SLC17A7 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A1 SLC2A2 SLC2A3 | 5.84e-07 | 736 | 55 | 14 | M27287 |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.76e-06 | 108 | 55 | 6 | M17034 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.21e-05 | 147 | 55 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.57e-05 | 151 | 55 | 6 | M39329 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.92e-05 | 103 | 55 | 5 | MM15196 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 5.21e-05 | 19 | 55 | 3 | MM14718 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.67e-05 | 54 | 55 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.67e-05 | 54 | 55 | 4 | MM15202 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.07e-05 | 176 | 55 | 6 | MM15718 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 7.11e-05 | 21 | 55 | 3 | M27058 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 7.54e-05 | 183 | 55 | 6 | M997 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 1.48e-04 | 5 | 55 | 2 | M49000 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.48e-04 | 130 | 55 | 5 | M27454 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 2.22e-04 | 6 | 55 | 2 | M47960 | |
| Pathway | WP_GLP1_IN_PANCREATIC_ISLET_CELLS | 3.10e-04 | 7 | 55 | 2 | M48339 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.16e-04 | 238 | 55 | 6 | MM15076 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.66e-04 | 36 | 55 | 3 | M39831 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.02e-04 | 249 | 55 | 6 | M5988 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 4.12e-04 | 8 | 55 | 2 | M27091 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING | 4.30e-04 | 38 | 55 | 3 | M39707 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.48e-04 | 165 | 55 | 5 | MM15026 | |
| Pathway | REACTOME_ADRENOCEPTORS | 5.29e-04 | 9 | 55 | 2 | M27302 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 5.29e-04 | 9 | 55 | 2 | M47852 | |
| Pathway | REACTOME_ADRENOCEPTORS | 5.29e-04 | 9 | 55 | 2 | MM15009 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 5.29e-04 | 9 | 55 | 2 | MM14769 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 6.41e-04 | 272 | 55 | 6 | M13380 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 6.59e-04 | 10 | 55 | 2 | M47661 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 7.10e-04 | 45 | 55 | 3 | M39474 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.04e-04 | 11 | 55 | 2 | M49033 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 8.04e-04 | 11 | 55 | 2 | M15422 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 8.04e-04 | 11 | 55 | 2 | M27466 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.62e-04 | 12 | 55 | 2 | MM1526 | |
| Pathway | REACTOME_SPHINGOLIPID_CATABOLISM | 9.62e-04 | 12 | 55 | 2 | M48264 | |
| Pathway | REACTOME_SPHINGOLIPID_CATABOLISM | 9.62e-04 | 12 | 55 | 2 | MM17238 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.03e-03 | 51 | 55 | 3 | MM15928 | |
| Pathway | WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS | 1.13e-03 | 13 | 55 | 2 | M48056 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.13e-03 | 13 | 55 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.13e-03 | 13 | 55 | 2 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.13e-03 | 13 | 55 | 2 | M47656 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.13e-03 | 13 | 55 | 2 | MM14553 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.14e-03 | 203 | 55 | 5 | M5485 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.28e-03 | 55 | 55 | 3 | M971 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 1.42e-03 | 57 | 55 | 3 | M39812 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.42e-03 | 57 | 55 | 3 | MM15643 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 1.52e-03 | 15 | 55 | 2 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 1.52e-03 | 15 | 55 | 2 | M47604 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.59e-03 | 129 | 55 | 4 | M5539 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 1.73e-03 | 16 | 55 | 2 | M39849 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.73e-03 | 16 | 55 | 2 | M26945 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.78e-03 | 133 | 55 | 4 | M16476 | |
| Pathway | WP_CORI_CYCLE | 1.96e-03 | 17 | 55 | 2 | M39604 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.15e-03 | 140 | 55 | 4 | M42572 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.20e-03 | 18 | 55 | 2 | MM15024 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 2.45e-03 | 19 | 55 | 2 | M27423 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.45e-03 | 19 | 55 | 2 | M27310 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.45e-03 | 19 | 55 | 2 | M47760 | |
| Pathway | WP_GPCRS_ORPHAN | 2.45e-03 | 19 | 55 | 2 | MM15991 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 2.45e-03 | 19 | 55 | 2 | M47733 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.56e-03 | 70 | 55 | 3 | M3115 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.71e-03 | 20 | 55 | 2 | M47688 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 2.71e-03 | 20 | 55 | 2 | MM15485 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 2.88e-03 | 73 | 55 | 3 | MM16641 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 2.99e-03 | 21 | 55 | 2 | M27736 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.99e-03 | 21 | 55 | 2 | M47689 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.00e-03 | 74 | 55 | 3 | MM15962 | |
| Pathway | WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING | 3.28e-03 | 22 | 55 | 2 | M39345 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.28e-03 | 22 | 55 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.28e-03 | 22 | 55 | 2 | M47675 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.37e-03 | 260 | 55 | 5 | M39397 | |
| Pathway | KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION | 3.59e-03 | 23 | 55 | 2 | M4361 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.59e-03 | 23 | 55 | 2 | M47676 | |
| Pathway | WP_TRIACYLGLYCERIDE_SYNTHESIS | 3.59e-03 | 23 | 55 | 2 | MM15890 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 3.60e-03 | 79 | 55 | 3 | M17673 | |
| Pathway | WP_TRIACYLGLYCERIDE_SYNTHESIS | 3.90e-03 | 24 | 55 | 2 | M39692 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 4.23e-03 | 25 | 55 | 2 | MM15931 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 4.23e-03 | 25 | 55 | 2 | MM14511 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 4.57e-03 | 26 | 55 | 2 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 4.57e-03 | 26 | 55 | 2 | MM15892 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 4.93e-03 | 27 | 55 | 2 | M12123 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 4.93e-03 | 27 | 55 | 2 | M39863 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.93e-03 | 27 | 55 | 2 | MM15053 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.08e-03 | 178 | 55 | 4 | M2890 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.29e-03 | 28 | 55 | 2 | M924 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 5.29e-03 | 28 | 55 | 2 | M10679 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 5.36e-03 | 91 | 55 | 3 | M48079 | |
| Pathway | WP_GPCRS_OTHER | 5.69e-03 | 93 | 55 | 3 | M39629 | |
| Pathway | PID_NECTIN_PATHWAY | 6.06e-03 | 30 | 55 | 2 | M72 | |
| Pathway | KEGG_ASTHMA | 6.06e-03 | 30 | 55 | 2 | M13950 | |
| Pubmed | 6.28e-11 | 117 | 66 | 8 | 17145500 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 22069254 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 21920790 | ||
| Pubmed | Structural analysis of the GLUT1 facilitative glucose transporter (review). | 2.61e-08 | 4 | 66 | 3 | 11681785 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 8457197 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 7653530 | ||
| Pubmed | Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos. | 2.61e-08 | 4 | 66 | 3 | 9688872 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 2656669 | ||
| Pubmed | Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. | 2.61e-08 | 4 | 66 | 3 | 8557327 | |
| Pubmed | Glucose uptake, utilization, and signaling in GLUT2-null islets. | 2.61e-08 | 4 | 66 | 3 | 10969832 | |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 6.51e-08 | 5 | 66 | 3 | 3035563 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 1638987 | ||
| Pubmed | The glucose transporter family: structure, function and tissue-specific expression. | 6.51e-08 | 5 | 66 | 3 | 8240230 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 1289053 | ||
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 3036582 | ||
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 18668520 | ||
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 22226978 | ||
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 21539827 | ||
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 16828986 | ||
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 19554504 | ||
| Pubmed | Novel mouse microsatellites: primer sequences and chromosomal location. | 1.42e-06 | 12 | 66 | 3 | 8535974 | |
| Pubmed | 1.76e-06 | 105 | 66 | 5 | 30280653 | ||
| Pubmed | Retrograde regulation of mossy fiber axon targeting and terminal maturation via postsynaptic Lnx1. | 1.84e-06 | 13 | 66 | 3 | 30185604 | |
| Pubmed | Osteoblast-specific expression of Panx3 is dispensable for postnatal bone remodeling. | 2.02e-06 | 108 | 66 | 5 | 31202927 | |
| Pubmed | Sequence determinants of GLUT1 oligomerization: analysis by homology-scanning mutagenesis. | 3.55e-06 | 2 | 66 | 2 | 23720776 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 38558087 | ||
| Pubmed | Lipid phosphate phosphatases dimerise, but this interaction is not required for in vivo activity. | 3.55e-06 | 2 | 66 | 2 | 14725715 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 31150793 | ||
| Pubmed | Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. | 3.55e-06 | 2 | 66 | 2 | 22270867 | |
| Pubmed | Fly and mammalian lipid phosphate phosphatase isoforms differ in activity both in vitro and in vivo. | 3.55e-06 | 2 | 66 | 2 | 12856002 | |
| Pubmed | Lipid phosphate phosphatases 1 and 3 are localized in distinct lipid rafts. | 3.55e-06 | 2 | 66 | 2 | 17005594 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 29027839 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16125330 | ||
| Pubmed | Null mutations in EphB receptors decrease sharpness of frequency tuning in primary auditory cortex. | 3.55e-06 | 2 | 66 | 2 | 22022561 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12112827 | ||
| Pubmed | Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents. | 3.55e-06 | 2 | 66 | 2 | 33402433 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27103070 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 32506584 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 18708078 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12165470 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 15201137 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28086215 | ||
| Pubmed | Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes. | 3.55e-06 | 2 | 66 | 2 | 10862609 | |
| Pubmed | GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. | 3.55e-06 | 2 | 66 | 2 | 20428049 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 10555956 | ||
| Pubmed | Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. | 3.55e-06 | 2 | 66 | 2 | 7593639 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 18401196 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 3.55e-06 | 2 | 66 | 2 | 23582047 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 22221271 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 1729614 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26807827 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28442571 | ||
| Pubmed | Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma. | 3.55e-06 | 2 | 66 | 2 | 24824030 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 33773574 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 31182397 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19303158 | ||
| Pubmed | Cell-autonomous role of EphB2 and EphB3 receptors in the thymic epithelial cell organization. | 3.55e-06 | 2 | 66 | 2 | 19731361 | |
| Pubmed | Expression of Glut-1 and Claudin-1 in follicular dendritic cell sarcoma. | 3.55e-06 | 2 | 66 | 2 | 18227718 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 9751501 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 34831313 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 7589840 | ||
| Pubmed | Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. | 3.55e-06 | 2 | 66 | 2 | 17122040 | |
| Pubmed | Glucose Transporters in Brain: In Health and in Alzheimer's Disease. | 3.55e-06 | 2 | 66 | 2 | 27858715 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 32589140 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 31832727 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 14527693 | ||
| Pubmed | Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma. | 3.55e-06 | 2 | 66 | 2 | 22064993 | |
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 3.55e-06 | 2 | 66 | 2 | 19120126 | |
| Pubmed | The Eph/ephrinB signal balance determines the pattern of T-cell maturation in the thymus. | 3.55e-06 | 2 | 66 | 2 | 21243004 | |
| Pubmed | Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. | 3.55e-06 | 2 | 66 | 2 | 9228080 | |
| Pubmed | Glucose transporter (Glut1, Glut3) mRNA in human placenta of diabetic and non-diabetic pregnancies. | 3.55e-06 | 2 | 66 | 2 | 10086067 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 18764953 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28631569 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 9305923 | ||
| Pubmed | EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. | 3.55e-06 | 2 | 66 | 2 | 16777604 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19536037 | ||
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 3.75e-06 | 55 | 66 | 4 | 32561725 | |
| Pubmed | 4.35e-06 | 17 | 66 | 3 | 26389685 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB2 EPHB3 HFE CNTNAP3B LRFN1 GBF1 PTPRM CNTNAP3 ERMP1 ATP12A CLDN1 | 4.68e-06 | 1061 | 66 | 11 | 33845483 |
| Pubmed | 5.22e-06 | 18 | 66 | 3 | 1765007 | ||
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 5.22e-06 | 18 | 66 | 3 | 18651661 | |
| Pubmed | 6.19e-06 | 19 | 66 | 3 | 15184386 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 10874040 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 31954765 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 9808793 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 16648270 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 11557593 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 20395455 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 20410461 | ||
| Pubmed | Genetic analysis of the role of Eph receptors in the development of the mammalian nervous system. | 1.06e-05 | 3 | 66 | 2 | 9321682 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 9705349 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 21298476 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 17437169 | ||
| Pubmed | Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase. | 1.06e-05 | 3 | 66 | 2 | 12471011 | |
| Pubmed | Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst. | 1.06e-05 | 3 | 66 | 2 | 9108057 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18194433 | ||
| Pubmed | A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development. | 1.06e-05 | 3 | 66 | 2 | 23143520 | |
| Pubmed | EphB receptor activity suppresses colorectal cancer progression. | 1.06e-05 | 3 | 66 | 2 | 15973414 | |
| Pubmed | Peritoneal Expression of SGLT-2, GLUT1, and GLUT3 in Peritoneal Dialysis Patients. | 1.06e-05 | 3 | 66 | 2 | 34781282 | |
| Pubmed | Determination of the HLA-DM interaction site on HLA-DR molecules. | 1.06e-05 | 3 | 66 | 2 | 11070170 | |
| Interaction | MPDU1 interactions | 1.03e-06 | 60 | 61 | 5 | int:MPDU1 | |
| Interaction | HLA-DRA interactions | 1.09e-05 | 166 | 61 | 6 | int:HLA-DRA | |
| Interaction | P2RY8 interactions | 1.67e-05 | 179 | 61 | 6 | int:P2RY8 | |
| Cytoband | 6p21.3 | 4.75e-04 | 250 | 66 | 4 | 6p21.3 | |
| Cytoband | 12p13.3 | 8.63e-04 | 30 | 66 | 2 | 12p13.3 | |
| Cytoband | 4q24 | 1.11e-03 | 34 | 66 | 2 | 4q24 | |
| Cytoband | 1q23.2 | 1.17e-03 | 35 | 66 | 2 | 1q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q24 | 3.30e-03 | 59 | 66 | 2 | chr4q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 4.29e-03 | 226 | 66 | 3 | chr1q23 | |
| GeneFamily | Solute carriers | SLC9B1 SLC26A3 SLC9B2 SLC17A7 SLC4A5 SLC2A1 SLC2A2 SLC2A3 SLC45A4 | 3.16e-06 | 395 | 56 | 9 | 752 |
| GeneFamily | Fibronectin type III domain containing | 9.85e-06 | 160 | 56 | 6 | 555 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 2.82e-05 | 3 | 56 | 2 | 297 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.96e-04 | 7 | 56 | 2 | 1208 | |
| GeneFamily | Phospholipid phosphatases | 1.96e-04 | 7 | 56 | 2 | 1067 | |
| GeneFamily | C1-set domain containing | 2.97e-04 | 42 | 56 | 3 | 591 | |
| GeneFamily | Adrenoceptors | 3.35e-04 | 9 | 56 | 2 | 169 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 8.37e-04 | 14 | 56 | 2 | 1095 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.55e-03 | 161 | 56 | 4 | 593 | |
| GeneFamily | CD molecules|Tetraspanins | 4.68e-03 | 33 | 56 | 2 | 768 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 8.20e-03 | 44 | 56 | 2 | 588 | |
| GeneFamily | Olfactory receptors, family 51 | 8.20e-03 | 44 | 56 | 2 | 164 | |
| GeneFamily | Immunoglobulin like domain containing | 2.19e-02 | 193 | 56 | 3 | 594 | |
| Coexpression | GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP | 8.00e-06 | 191 | 65 | 6 | M3310 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 9.27e-06 | 196 | 65 | 6 | M8135 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS | 1.53e-05 | 214 | 65 | 6 | M40005 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 4.46e-05 | 681 | 65 | 9 | M5314 | |
| Coexpression | GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP | 1.28e-04 | 196 | 65 | 5 | M5189 | |
| Coexpression | GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP | 1.28e-04 | 196 | 65 | 5 | M7238 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 1.28e-04 | 196 | 65 | 5 | M6227 | |
| Coexpression | GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN | 1.37e-04 | 199 | 65 | 5 | M8367 | |
| Coexpression | GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN | 1.40e-04 | 200 | 65 | 5 | M5104 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN | 1.40e-04 | 200 | 65 | 5 | M6261 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP | 1.40e-04 | 200 | 65 | 5 | M6558 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 1.40e-04 | 200 | 65 | 5 | M9133 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | TSPAN12 CACNA1C PTPRM CD164 GJC1 ATP1A2 SLC2A2 SLC2A3 ADGRD1 | 1.45e-04 | 795 | 65 | 9 | M39050 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.97e-06 | 312 | 61 | 8 | gudmap_kidney_adult_RenMedVasc_Tie2_k2_1000 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000 | TSPAN12 OR51E1 PLPP1 HLA-DMA PLPP3 PTPRM HLA-DRA MFSD6 TSPAN8 CD47 SEMA3G ITPR2 | 4.27e-06 | 846 | 61 | 12 | gudmap_kidney_adult_CortVasc_Tie2_1000 |
| CoexpressionAtlas | smooth muscle | 6.03e-06 | 90 | 61 | 5 | smooth muscle | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 7.31e-06 | 163 | 61 | 6 | gudmap_kidney_adult_CortVasc_Tie2_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 1.21e-05 | 378 | 61 | 8 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_500 | 2.45e-05 | 417 | 61 | 8 | gudmap_kidney_adult_CortVasc_Tie2_500 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_500 | 2.90e-05 | 427 | 61 | 8 | gudmap_kidney_adult_GlomCapSys_Tie2_500 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_500 | 3.48e-05 | 438 | 61 | 8 | gudmap_kidney_adult_RenCorpuscGlomer_500 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.49e-05 | 142 | 61 | 5 | gudmap_kidney_adult_Podocyte_MafB_k2_1000 | |
| CoexpressionAtlas | placenta | 6.21e-05 | 349 | 61 | 7 | placenta | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | PDPN PLPP1 HLA-DMA PLPP3 FAT3 TSPAN8 CNTNAP3 CD47 ADGRD1 CLDN1 | 6.83e-05 | 778 | 61 | 10 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | TSPAN12 PDPN ABCA2 ADRB2 PLPP1 MFSD6 TSPAN8 CD47 SEMA3G CLDN1 | 1.26e-04 | 838 | 61 | 10 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_200 | 1.36e-04 | 172 | 61 | 5 | gudmap_kidney_adult_RenMedVasc_Tie2_200 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | TSPAN12 HFE PLPP1 HLA-DMA PLPP3 PTPRM HLA-DRA MFSD6 TSPAN8 CD47 | 1.42e-04 | 850 | 61 | 10 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 1.66e-04 | 409 | 61 | 7 | GSM538234_500 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | TSPAN12 PDPN PLPP1 PLPP3 PTPRM MFSD6 TSPAN8 CD47 SEMA3G CLDN1 | 1.84e-04 | 878 | 61 | 10 | gudmap_kidney_adult_RenCorpuscGlomer_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.04e-04 | 721 | 61 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.06e-04 | 722 | 61 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | EPHB2 TPRA1 ABCA2 GBF1 PLPP3 SLC9B2 CNTNAP3 CD47 FAM171B ATP1A2 CLDN1 | 2.16e-04 | 1075 | 61 | 11 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_500 | 2.20e-04 | 103 | 61 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k3 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | TSPAN12 GPR161 TPRA1 ABCA2 GBF1 PTPRM SLC9B2 CNTNAP3 CD47 FAM171B ATP1A2 CLDN1 CAP2 | 2.22e-04 | 1466 | 61 | 13 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.27e-04 | 302 | 61 | 6 | gudmap_kidney_adult_CortVasc_Tie2_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.55e-04 | 743 | 61 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.65e-04 | 747 | 61 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 3.09e-04 | 320 | 61 | 6 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.34e-04 | 47 | 61 | 3 | gudmap_kidney_adult_Podocyte_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | 3.44e-04 | 774 | 61 | 9 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_500 | 3.47e-04 | 116 | 61 | 4 | gudmap_kidney_adult_RenCorpuscGlomer_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.64e-04 | 658 | 61 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#4_top-relative-expression-ranked_500 | 6.51e-04 | 137 | 61 | 4 | gudmap_kidney_adult_GlomCapSys_Tie2_k4_500 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_1000 | 6.89e-04 | 852 | 61 | 9 | gudmap_kidney_adult_GlomCapSys_Tie2_1000 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-08 | 199 | 66 | 7 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.40e-07 | 186 | 66 | 6 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-07 | 187 | 66 | 6 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 3.74e-07 | 189 | 66 | 6 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-07 | 189 | 66 | 6 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-07 | 189 | 66 | 6 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-07 | 190 | 66 | 6 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-07 | 190 | 66 | 6 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.10e-07 | 192 | 66 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-07 | 194 | 66 | 6 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.77e-07 | 197 | 66 | 6 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-07 | 200 | 66 | 6 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 4.13e-06 | 161 | 66 | 5 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.26e-06 | 162 | 66 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.39e-06 | 163 | 66 | 5 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-06 | 165 | 66 | 5 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 5.86e-06 | 173 | 66 | 5 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 6.03e-06 | 174 | 66 | 5 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 176 | 66 | 5 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.92e-06 | 179 | 66 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.92e-06 | 179 | 66 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.11e-06 | 180 | 66 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.11e-06 | 180 | 66 | 5 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.50e-06 | 182 | 66 | 5 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.70e-06 | 183 | 66 | 5 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 184 | 66 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.91e-06 | 184 | 66 | 5 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.12e-06 | 185 | 66 | 5 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.12e-06 | 185 | 66 | 5 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.12e-06 | 185 | 66 | 5 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.55e-06 | 187 | 66 | 5 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class （2021.01.30） | 8.55e-06 | 187 | 66 | 5 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.55e-06 | 187 | 66 | 5 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.55e-06 | 187 | 66 | 5 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.55e-06 | 187 | 66 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.55e-06 | 187 | 66 | 5 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 8.78e-06 | 188 | 66 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.78e-06 | 188 | 66 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 188 | 66 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 8.78e-06 | 188 | 66 | 5 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-06 | 188 | 66 | 5 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 189 | 66 | 5 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 9.01e-06 | 189 | 66 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-06 | 189 | 66 | 5 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.24e-06 | 190 | 66 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.24e-06 | 190 | 66 | 5 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 9.24e-06 | 190 | 66 | 5 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 191 | 66 | 5 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 191 | 66 | 5 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.48e-06 | 191 | 66 | 5 | adb2e3efcad02889d8229325080da5e7830fd3ae | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 191 | 66 | 5 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.48e-06 | 191 | 66 | 5 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 191 | 66 | 5 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 9.72e-06 | 192 | 66 | 5 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.72e-06 | 192 | 66 | 5 | dfa6adc776621f4b51d731b796c0421855b2297c | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.72e-06 | 192 | 66 | 5 | 6b69bb8fab9b470850eba1a070a500435ec233cd | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | 5a92697430f16c49e19a5f727d289d7bd1ece31c | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | 64bcdbb422f8da6fc3275e82f6aaf562f546a180 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 9.97e-06 | 193 | 66 | 5 | c97f9b13057f803df63c696c6175ef8e0aba6fa7 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 194 | 66 | 5 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.02e-05 | 194 | 66 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 194 | 66 | 5 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-05 | 194 | 66 | 5 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 194 | 66 | 5 | 8deeb3e00237e3d9ad5a1457cd0061576421b9e9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 194 | 66 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 194 | 66 | 5 | b81801fb16e8bd0d6083fe32866051d3c60f3dc7 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 194 | 66 | 5 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 195 | 66 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 197 | 66 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 197 | 66 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-05 | 197 | 66 | 5 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-05 | 197 | 66 | 5 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 197 | 66 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 367C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 197 | 66 | 5 | f5c21f0d363b5c298a2b82f6dff4f369397b5f25 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 198 | 66 | 5 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 198 | 66 | 5 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-05 | 198 | 66 | 5 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 66 | 5 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-05 | 199 | 66 | 5 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.16e-05 | 199 | 66 | 5 | 80c8641cfd84436eadf2234f1313749e2f73331f | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 199 | 66 | 5 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 199 | 66 | 5 | fff88d2bba262583bb726900ae01e44954b72eb9 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.16e-05 | 199 | 66 | 5 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 199 | 66 | 5 | e6715288a586631676722f2323f0d833431161cf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 199 | 66 | 5 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 199 | 66 | 5 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.16e-05 | 199 | 66 | 5 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 199 | 66 | 5 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | e90ca26643f8496bdd6672c327da9855490d1aa8 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.18e-05 | 200 | 66 | 5 | f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.39e-05 | 145 | 66 | 4 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.10e-05 | 149 | 66 | 4 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-05 | 154 | 66 | 4 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-05 | 158 | 66 | 4 | 41cf950983f47a9e55d56041b301006b42853b37 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.58e-05 | 161 | 66 | 4 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.58e-05 | 161 | 66 | 4 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 163 | 66 | 4 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 1.00e-04 | 163 | 66 | 4 | 30f5c93c4e170304d701b5231f0d545f404066f7 | |
| Drug | sodium | CACNA1C SLC26A3 ATP6V0B PTPRM SLC9B2 SLC17A7 GRIK4 ATP1A2 ATP12A ATP1A4 SLC4A5 SLC2A1 SLC2A2 SLC2A3 | 3.42e-07 | 944 | 65 | 14 | CID000000923 |
| Drug | L-I TC | 1.23e-06 | 8 | 65 | 3 | CID000129434 | |
| Drug | NBDG | 1.84e-06 | 9 | 65 | 3 | CID000163790 | |
| Drug | ethylidene glucose | 3.60e-06 | 11 | 65 | 3 | CID000093075 | |
| Drug | IAPS-forskolin | 4.80e-06 | 12 | 65 | 3 | CID000163853 | |
| Drug | Dehydroascorbic Acid | 6.22e-06 | 13 | 65 | 3 | ctd:D003683 | |
| Drug | ATB-BMPA | 7.90e-06 | 14 | 65 | 3 | CID000122117 | |
| Drug | 3-O-Methylglucose | 8.03e-06 | 2 | 65 | 2 | ctd:D019325 | |
| Drug | Synephrine | 1.21e-05 | 16 | 65 | 3 | ctd:D013578 | |
| Drug | 4,6-O-ethylidene-D-glucose | 1.21e-05 | 16 | 65 | 3 | CID000114511 | |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.87e-05 | 193 | 65 | 6 | 6103_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.93e-05 | 194 | 65 | 6 | 7413_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 7300_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 3693_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 5723_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; PC3; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 3755_UP | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 5906_DN | |
| Drug | Maltose | 2.40e-05 | 3 | 65 | 2 | ctd:D008320 | |
| Drug | T 1095 | 2.45e-05 | 20 | 65 | 3 | CID006918410 | |
| Drug | TF-3 | 2.85e-05 | 21 | 65 | 3 | CID006102763 | |
| Drug | paramethoxyphenyl-acetyl dehydroalanine | 4.55e-05 | 69 | 65 | 4 | CID000130300 | |
| Drug | Cytochalasin B | 4.88e-05 | 25 | 65 | 3 | ctd:D003571 | |
| Drug | 1 sulfonylurea | 5.56e-05 | 143 | 65 | 5 | CID011819083 | |
| Drug | metformin | 5.63e-05 | 235 | 65 | 6 | CID000004091 | |
| Drug | phlorizine | 7.74e-05 | 79 | 65 | 4 | CID000004789 | |
| Drug | alpha-ketoisocaproate | 7.74e-05 | 79 | 65 | 4 | CID000000070 | |
| Drug | Coal Ash | 9.19e-05 | 159 | 65 | 5 | ctd:D060729 | |
| Drug | AC1L1BXF | 1.03e-04 | 85 | 65 | 4 | CID000001650 | |
| Drug | octylglucopyranoside | 1.03e-04 | 163 | 65 | 5 | CID000062080 | |
| Drug | 3-OMG | 1.14e-04 | 33 | 65 | 3 | CID000097217 | |
| Drug | diethylmalonic acid | 1.19e-04 | 6 | 65 | 2 | CID000068185 | |
| Drug | DiC8-PA | 1.19e-04 | 6 | 65 | 2 | CID000128167 | |
| Drug | 4-chlorobutanol | 1.19e-04 | 6 | 65 | 2 | CID000013569 | |
| Drug | Phenoxybenzamine | 1.19e-04 | 6 | 65 | 2 | DB00925 | |
| Drug | chromium picolinate | 1.25e-04 | 34 | 65 | 3 | CID000151932 | |
| Drug | Trinitrobenzenesulfonic Acid | 1.33e-04 | 396 | 65 | 7 | ctd:D014302 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.37e-04 | 173 | 65 | 5 | 2105_UP | |
| Drug | 1,2-diglyceride | 1.44e-04 | 175 | 65 | 5 | CID000192866 | |
| Drug | Phloretin | 1.61e-04 | 37 | 65 | 3 | ctd:D010693 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.64e-04 | 180 | 65 | 5 | 5950_UP | |
| Drug | o-chlorobenzylsulfonamide | 1.67e-04 | 7 | 65 | 2 | CID000146065 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.96e-04 | 187 | 65 | 5 | 3077_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.01e-04 | 188 | 65 | 5 | 3823_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.11e-04 | 190 | 65 | 5 | 5080_DN | |
| Drug | DAR-0100A | 2.19e-04 | 41 | 65 | 3 | CID000060759 | |
| Drug | NSC-327434 | 2.22e-04 | 8 | 65 | 2 | CID000332025 | |
| Drug | PDCP | 2.22e-04 | 8 | 65 | 2 | CID000098627 | |
| Drug | S 422 | 2.22e-04 | 8 | 65 | 2 | CID000035748 | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 2.27e-04 | 193 | 65 | 5 | 4125_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.27e-04 | 193 | 65 | 5 | 6678_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.27e-04 | 193 | 65 | 5 | 3378_DN | |
| Drug | semustine; Down 200; 100uM; PC3; HT_HG-U133A | 2.33e-04 | 194 | 65 | 5 | 7545_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 194 | 65 | 5 | 6769_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.33e-04 | 194 | 65 | 5 | 3213_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 65 | 5 | 3321_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 65 | 5 | 4141_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.38e-04 | 195 | 65 | 5 | 4309_UP | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 65 | 5 | 4170_DN | |
| Drug | Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.44e-04 | 196 | 65 | 5 | 2871_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.44e-04 | 196 | 65 | 5 | 7129_UP | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.44e-04 | 196 | 65 | 5 | 6757_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.44e-04 | 196 | 65 | 5 | 1497_UP | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 3615_DN | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 2720_UP | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 3540_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 3934_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 5761_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 3930_DN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 3635_DN | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 4130_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; HL60; HG-U133A | 2.50e-04 | 197 | 65 | 5 | 1997_UP | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 2486_UP | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 6812_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; HL60; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 6160_UP | |
| Drug | Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 2178_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A | 2.56e-04 | 198 | 65 | 5 | 1553_UP | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 5988_UP | |
| Drug | Nitrofural [59-87-0]; Up 200; 20.2uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 6721_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 5663_UP | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 2653_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 1694_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 3895_DN | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 65 | 5 | 3882_DN | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 2.62e-04 | 199 | 65 | 5 | 3036_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; PC3; HT_HG-U133A | 2.62e-04 | 199 | 65 | 5 | 4067_UP | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.62e-04 | 199 | 65 | 5 | 6675_DN | |
| Drug | Avermectin B1 [71751-41-2]; Up 200; 4.8uM; PC3; HT_HG-U133A | 2.62e-04 | 199 | 65 | 5 | 5864_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; HL60; HT_HG-U133A | 2.68e-04 | 200 | 65 | 5 | 6123_UP | |
| Drug | norethisterone oenanthate | 2.69e-04 | 109 | 65 | 4 | CID000019688 | |
| Drug | AC1NSOIE | 2.85e-04 | 9 | 65 | 2 | CID005313199 | |
| Drug | propyl pyrazole triol | 2.85e-04 | 9 | 65 | 2 | CID006095481 | |
| Drug | cycloalliin | 2.85e-04 | 9 | 65 | 2 | CID000193294 | |
| Drug | 3-deoxyfructose | 2.85e-04 | 9 | 65 | 2 | CID003080627 | |
| Drug | Palmitoyl | 2.85e-04 | 9 | 65 | 2 | CID000089566 | |
| Drug | 1yej | 2.89e-04 | 45 | 65 | 3 | CID000449245 | |
| Drug | DETA | 3.19e-04 | 114 | 65 | 4 | CID000004284 | |
| Drug | alpha-methyl-D-mannoside | 3.41e-04 | 116 | 65 | 4 | CID000002108 | |
| Drug | 6,7-dihydro-5H-dibenz(c,e)azepine | 3.56e-04 | 10 | 65 | 2 | CID000081183 | |
| Drug | isoetharine | 3.56e-04 | 10 | 65 | 2 | CID000003762 | |
| Drug | Norepinephrine | 3.56e-04 | 10 | 65 | 2 | DB00368 | |
| Disease | Bipolar Disorder | CACNA1C ADRA2C ADRB2 MCHR2 TSPAN8 CD47 SLC17A7 GRIK4 ATP1A2 ITPR1 | 6.59e-08 | 477 | 63 | 10 | C0005586 |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 3.23e-07 | 7 | 63 | 3 | DOID:0060178 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 2.01e-06 | 12 | 63 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | Anoxic Encephalopathy | 4.49e-06 | 2 | 63 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 4.49e-06 | 2 | 63 | 2 | C1527348 | |
| Disease | Anoxia of brain | 4.49e-06 | 2 | 63 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 4.49e-06 | 2 | 63 | 2 | C1140716 | |
| Disease | response to fluoropyrimidines | 4.49e-06 | 2 | 63 | 2 | EFO_0010825 | |
| Disease | Abnormality of refraction | 9.01e-05 | 673 | 63 | 8 | HP_0000539 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.25e-04 | 8 | 63 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Peritoneal Neoplasms | 2.00e-04 | 10 | 63 | 2 | C0031149 | |
| Disease | Carcinomatosis of peritoneal cavity | 2.00e-04 | 10 | 63 | 2 | C0346990 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.92e-04 | 12 | 63 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 4.15e-04 | 163 | 63 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | response to olanzapine | 4.63e-04 | 15 | 63 | 2 | GO_0097333 | |
| Disease | Depression, Bipolar | 6.53e-04 | 79 | 63 | 3 | C0005587 | |
| Disease | alcohol drinking | 7.03e-04 | 81 | 63 | 3 | EFO_0004329 | |
| Disease | Cardiac Hypertrophy | 7.28e-04 | 82 | 63 | 3 | C1383860 | |
| Disease | Cardiomegaly | 7.28e-04 | 82 | 63 | 3 | C0018800 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.12e-04 | 195 | 63 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | obesity (is_implicated_in) | 9.86e-04 | 91 | 63 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | asthma exacerbation measurement | 1.05e-03 | 93 | 63 | 3 | EFO_0007614 | |
| Disease | obesity (implicated_via_orthology) | 1.17e-03 | 215 | 63 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Anhedonia | 1.20e-03 | 24 | 63 | 2 | C0178417 | |
| Disease | hypertension (biomarker_via_orthology) | 1.42e-03 | 227 | 63 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | cystic fibrosis (is_implicated_in) | 1.52e-03 | 27 | 63 | 2 | DOID:1485 (is_implicated_in) | |
| Disease | Crohn's disease (is_implicated_in) | 1.88e-03 | 30 | 63 | 2 | DOID:8778 (is_implicated_in) | |
| Disease | Ventricular Dysfunction, Left | 1.88e-03 | 30 | 63 | 2 | C0242698 | |
| Disease | adult onset asthma | 2.08e-03 | 118 | 63 | 3 | EFO_1002011 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLIVLAIVFGNVLVI | 41 | P07550 | |
| VIGGVIAVVIFILLC | 1246 | Q9BZ76 | |
| VLVVLGVVLLGQFVV | 191 | Q16611 | |
| LFVIVVNIGILIAVT | 721 | Q6QNK2 | |
| LIVFTVVGNVLVVIA | 61 | P18825 | |
| VTVLIIAVFISLIGQ | 466 | Q7Z2K6 | |
| AFIVVGNLVIITVVQ | 36 | Q8NGY2 | |
| FIVIIIVLNLIFGVI | 2526 | Q14571 | |
| YNVTVLGNIGLIVII | 36 | Q8NGL1 | |
| IIIGGIIVASVLVFI | 531 | Q96NI6 | |
| YGLIITGNILIVVSI | 26 | Q8NGF6 | |
| FVVGVIGNVLVCLVI | 56 | Q9GZQ4 | |
| INVVGVVVTFLVLLI | 381 | Q8N468 | |
| IIIVLNLIFGVIIDT | 2586 | Q14643 | |
| QLGIVVGILIAQVFG | 161 | P11166 | |
| FIGGIVLVLGVQAVI | 166 | Q04900 | |
| GGVIVASVLVFIVLL | 541 | Q9P244 | |
| QVLDSIIFLIGIIVA | 331 | P54707 | |
| IIFLIGIIVANVPEG | 336 | P54707 | |
| LGLVFDNVVGIVEVI | 381 | P40123 | |
| GLVFLIAVVVIAIVC | 551 | P29323 | |
| LPVLLVIVIFAAVGV | 951 | O60486 | |
| VNVVYGLIVIISAIG | 196 | Q8TCB6 | |
| VIITGQQVVRAGLIV | 146 | Q9H341 | |
| IVTGILISQIIGLEF | 196 | P11168 | |
| AGLVFVVAVVVIAIV | 566 | P54753 | |
| VGQVLVILVFVLSIG | 101 | A8MYU2 | |
| IALGGVIVASVLVFI | 541 | Q9BTN0 | |
| VIGVISGIAVFVVIL | 306 | Q30201 | |
| AIFLVILVVVIIGEF | 286 | Q6ZSS7 | |
| LEQVTVPIGVLLVIF | 466 | P54886 | |
| STGLVGNILIVFTII | 46 | Q969V1 | |
| LEAVIFLIGIIVANV | 316 | P50993 | |
| IIVVVGLFSAILEQA | 201 | Q13936 | |
| VGILLGVIAIFVATV | 86 | O95832 | |
| TVLIVFRIVLTAVGG | 26 | P36383 | |
| IGIAVVLFVIFILVV | 4156 | Q8TDW7 | |
| VLGIIVGIVLIIYFR | 241 | P28067 | |
| LLQGTDVVIAIFIIV | 1786 | Q9BZC7 | |
| VGLVGIIIGTIFIIK | 226 | P01903 | |
| IYIIQGEINIVVGAI | 6 | Q92538 | |
| VITIFVCLGNLVIVV | 36 | Q8N6U8 | |
| GIVVGILVAQIFGLE | 161 | P11169 | |
| ITVIVIVGAILFVPG | 186 | Q08722 | |
| GGIFVVLICGLIVAI | 806 | Q16099 | |
| LTAILGGTIVIVIGF | 356 | Q6P995 | |
| VIGGVIAVEIFILLC | 1246 | Q96NU0 | |
| VKIAGVIAGILLFVI | 741 | P28827 | |
| GLIVLLYSVVVVVGL | 61 | P49683 | |
| VGIVIAILAIITGEF | 91 | O14495 | |
| VGVLLAIGFIGAIIV | 136 | Q86YL7 | |
| GIIIPFSIIVIILGE | 61 | O14494 | |
| FNVLRGVLEVVIGVA | 301 | Q86UD5 | |
| GLPVVTVIVAVFVLL | 41 | A0A1B0GW64 | |
| CVIFVRILQGLVEGV | 171 | Q9P2U7 | |
| IGAIIVLIVVLAIGF | 416 | P40879 | |
| LEAIIFLIGIIVANV | 326 | Q13733 | |
| IGIVLTVLGVVVLDF | 156 | Q5BKX6 | |
| FIVVAGVVILAVTIA | 21 | O60235 | |
| LVFVVALVGIARAVV | 86 | Q86W33 | |
| IGNVEISQVTIVGII | 66 | P15927 | |
| IGLFGVIVAILQTSR | 186 | Q99437 | |
| TSIFLGVITVIIIGL | 71 | Q5BVD1 | |
| EQRVTGIIVFILTGI | 926 | Q9BY07 | |
| RGVLNVIITNGVILF | 61 | Q4ZJI4 | |
| QVLRFLGISIGVTQI | 221 | O95859 | |
| GFSQTVVRLALVVIV | 661 | Q9NS98 | |
| LIIVIGISFGLAVIE | 206 | P19075 |